Actimmune: Began Phase II trial

InterMune Pharmaceuticals Inc. (ITMN), Burlingame, Calif.
Product: Actimmune

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE